35 research outputs found
Epidermal Barrier Function and Skin Homeostasis in Skin with Permanent and Adhesive Tattoos: A Cross-Sectional Study
Tattoos are a current trend, but their impact on skin homeostasis and epidermal barrier
function is not well known. So, the aims of this study are (1) to investigate epidermal barrier function
and skin homeostasis in skin with permanent tattoos, adhesive temporary tattoos and non-tattooed
skin, and (2) to analyze the effect of petrolatum on skin with permanent and adhesive tattoos. In total,
67 tattoos were enrolled (34 permanent tattoos and 33 adhesive tattoos). Temperature, transepidermal
water loss (TEWL), stratum corneum hydration (SCH), erythema and total antioxidant capacity (TAC)
were measured in skin with permanent tattoos, adhesive tattoos and non-tattooed skin before and
after petrolatum application. The temperature was lower (30.47 C vs. 31.01 C; p = 0.001) on skin
with permanent tattoos than non-tattooed skin, while SCH (48.24 Arbitrary Units (AU) vs. 44.15 AU;
p = 0.008) was higher. Skin with adhesive tattoos showed lower temperature, SCH (21.19 AU vs.
41.31 AU; p < 0.001) and TAC (1.27 microcoulombs (uC) vs. 3.48 uC; p < 0.001), and higher TEWL
(8.65 g/h/m2 vs. 6.99 g/h/m2; p = 0.003), than non-tattooed skin. After petrolatum application, the
temperature decreased on skin with permanent tattoos, and TEWL and SCH decreased on skin with
adhesive tattoos. Adhesive tattoos may affect skin barrier function, while permanent tattoos may
have a lower impact. Tattooed and non-tattooed skin responds in different ways to moisturizers
Current Advanced Therapies Based on Human Mesenchymal Stem Cells for Skin Diseases
Skin disease may be related with immunological disorders, external aggressions, or
genetic conditions. Injuries or cutaneous diseases such as wounds, burns, psoriasis,
and scleroderma among others are common pathologies in dermatology, and in some
cases, conventional treatments are ineffective. In recent years, advanced therapies
using human mesenchymal stem cells (hMSCs) from different sources has emerged
as a promising strategy for the treatment of many pathologies. Due to their properties;
regenerative, immunomodulatory and differentiation capacities, they could be applied
for the treatment of cutaneous diseases. In this review, a total of thirteen types of
hMSCs used as advanced therapy have been analyzed, considering the last 5 years
(2015–2020). The most investigated types were those isolated from umbilical cord
blood (hUCB-MSCs), adipose tissue (hAT-MSCs) and bone marrow (hBM-MSCs). The
most studied diseases were wounds and ulcers, burns and psoriasis. At preclinical
level, in vivo studies with mice and rats were the main animal models used, and a
wide range of types of hMSCs were used. Clinical studies analyzed revealed that cell
therapy by intravenous administration was the advanced therapy preferred except in
the case of wounds and burns where tissue engineering was also reported. Although
in most of the clinical trials reviewed results have not been posted yet, safety was high
and only local slight adverse events (mild nausea or abdominal pain) were reported.
In terms of effectiveness, it was difficult to compare the results due to the different
doses administered and variables measured, but in general, percentage of wound’s
size reduction was higher than 80% in wounds, Psoriasis Area and Severity Index
and Severity Scoring for Atopic Dermatitis were significantly reduced, for scleroderma,
parameters such as Modified Rodnan skin score (MRSC) or European Scleroderma
Study Group activity index reported an improvement of the disease and for hypertrophic
scars, Vancouver Scar Scale (VSS) score was decreased after applying these therapies.
On balance, hMSCs used for the treatment of cutaneous diseases is a promising
strategy, however, the different experimental designs and endpoints stablished in each
study, makes necessary more research to find the best way to treat each patient
and disease.Instituto de Salud Carlos III (European Regional Development Fund "A way to make Europe")
PI13/02576
PI17/02083Andalusian Regional Government
SAS PI-0458-2016
PIGE-0242-2019Instituto de Salud Carlos III (European Social Fund "Investing in your future")
FI18/0026
An Updated in the Management of Alopecia Areata
Alopecia areata (AA) is the most frequent type of non-scarring alopecia after androgenetic alopecia. The lifetime risk of developing AA is approximately 1.7–2.1%, and its incidence is increasing over time. Clinically, it is characterized by circumscribed and smooth patches of alopecia with black dots. Several treatments have been used in AA including topical an oral minoxidil and corticosteroids. Although new treatment options are being developed and advances have been made in recent years, there is currently no preventive or curative treatment for AA and classical treatments produce variable results. The design of a treatment strategy for alopecia areata should be based on consensual decision-making with the patient, taking into account his or her preferences and the risk and benefit of each treatment. In this chapter, we review the treatment of AA
Reproductive Potential and Outcomes in Patients with Hidradenitis Suppurativa: Clinical Profile and Therapeutic Implications
We would like to thank Charlotte Bower for improving the English of this
manuscript.There are scarce data available regarding the impact of hidradenitis suppurativa (HS) on fertility, course and outcome of pregnancy and risk associated with treatments. The aims of this study are (1) to describe the clinical profile of HS women of childbearing age with and without accomplished reproductive desires and (2) to describe the prescribed treatments based on the fulfillment of reproductive intentions. We conducted a prospective observational study that included 104 HS women of childbearing age, 50.96% (53/104) with unfulfilled reproductive desires. These women were younger (29.08 vs. 42.06 years, p < 0.001), less frequently married and higher educated than women with fulfilled reproductive desires. Their age of disease onset was lower, but disease duration was shorter, in concordance with a lower International Hidradenitis Suppurativa Severity Score System (IHS4) and lower number of draining tunnels. Combined oral contraceptives were more frequently prescribed in women with unfulfilled reproductive desires (30.19% vs. 9.80%, p = 0.013) while biologics were less used in this group (3.77% vs. 13.73%, p = 0.08). In conclusion, a higher educational level and an earlier disease onset, with potential implications in finding a partner, may make the fulfillment of reproductive desires difficult for patients with HS. This study could help clinicians to achieve a better understanding of the specific characteristics of HS during childbearing age and consider reproductive desires when making treatment decisions
Cumulative Inflammation and HbA1c Levels Correlate with Increased Intima‐Media Thickness in Patients with Severe Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that has been
associated with a greater risk of metabolic and cardiovascular comorbidities. The aim of this study
is to assess cardiovascular risk by means of intima‐media thickness (IMT), metabolic syndrome, and
other potential biomarkers in patients with severe hidradenitis suppurativa who are candidates for
biologic therapy and to explore potentially associated factors. A cross‐sectional study was
performed. Body mass index (BMI), carotid intima‐media thickness (IMT), and blood tests,
including glycemic and lipid profile, insulin, vitamin D, and inflammation markers were
performed. Fifty patients were included in the study; the male/female ratio was 3:2. The mean age
was 38 years, and the mean disease duration was 21.8 years. The mean carotid IMT was 651.39 μm.
A positive association of IMT with disease duration, tobacco consumption, and HbA1c levels was
observed. HbA1c correlated with the age of onset, hypertension, metabolic syndrome, and glucose
levels. Vitamin D levels inversely correlated with the number of areas affected. In conclusion,
patients with severe HS present a higher cardiovascular risk, but it is not distributed equally within
the patients: Tobacco consumption, inadequate glycemic control, and disease duration could be
useful clinical and biochemical markers to identify patients at higher risk
The Role of Exosomes Derived From Mesenchymal Stromal Cells in Dermatology
This study has been funded by the Carlos III Health Institute of Spain through the PI13/02576 and PI17/02083 projects [cofunded by European Regional Development Fund "A way to make Europe" and Andalusian Regional Government Finance (SAS PI-0458-2016)]. The work of MQ-V was supported by a predoctoral fellowship (BOE 22/10/2019) from the Spanish Ministry of Science, Innovation and Universities. This study is part of her doctoral research in the Biomedicine program at the University of Granada.The skin is the largest organ of the human body and its main functions include providing protection from external harmful agents, regulating body temperature, and homeostatic maintenance. Skin injuries can damage this important barrier and its functions so research focuses on approaches to accelerate wound healing and treat inflammatory skin diseases. Due to their regenerative and immunomodulatory properties, mesenchymal stromal cells (MSCs) have been reported to play a significant role in skin repair and regeneration. However, it seems that the secretome of these cells and exosomes in particular may be responsible for their functions in skin regeneration and the immunomodulation field. The present review aims to gather the available information about the role of MSC-derived exosomes for both in vitro and in vivo models of different skin conditions and to highlight the need for further research in order to overcome any limitations for clinical translation.Carlos III Health Institute of Spain [European Regional Development Fund "A way to make Europe"]
PI13/02576
PI17/02083Carlos III Health Institute of Spain [Andalusian Regional Government Finance]
PI13/02576
PI17/02083
SAS PI-0458-2016Spanish Ministry of Science, Innovation and Universities
BOE 22/10/201
Erythema Increase Predicts Psoriasis Improvement after Phototherapy
Psoriasis is a major global health problem. There is a need to develop techniques to help
physicians select the most appropriate cost-effective therapy for each patient. The main objectives
of this study are (1) to evaluate changes in epidermal barrier function and skin homeostasis after
phototherapy and (2) to explore potentially predictive values in epidermal barrier function and
skin homeostasis to assess clinical improvement after fifteen sessions of phototherapy. A total
of 76 subjects, 38 patients with plaque-type psoriasis and 38 gender- and age-matched healthy
volunteers, were included in the study. Erythema, transepidermal water loss (TEWL), temperature,
stratum corneum hydration (SCH), pH, sebum, and antioxidant capacity were measured before
and after the first and fifteenth phototherapy session. Erythema (401.09 vs. 291.12 vs. 284.52 AU,
p < 0.001) and TEWL (18.23 vs. 11.44 vs. 11.41 g·m−2
·h
−1
, p < 0.001) were significantly higher at
psoriatic plaques than in uninvolved psoriatic skin and healthy volunteers, respectively, while SCH
was lower (9.71 vs. 44.64 vs. 40.00 AU, p < 0.001). After fifteen phototherapy sessions, TEWL
(–5.19 g·m−2
·h
−1
, p = 0.016) decreased while SCH (+7.01 AU, p = 0.013) and erythema (+30.82 AU,
p = 0.083) increased at psoriatic plaques. An erythema increase exceeding 53.23 AU after the first
phototherapy session, with a sensitivity of 71.4% and specificity of 84.2%, indicates that a patient may
improve Psoriasis Area and Severity Index (PASI) by ≥3 points after fifteen phototherapy sessions. In
conclusion, phototherapy improves epidermal barrier function in psoriatic patients and the erythema
increase after one phototherapy session could help doctors select psoriasis patients who are more
likely to respond to phototherapy
Itchy Capillary Malformations: Unusual Appearance of Meyerson Phenomenon, a Case Series
Meyerson phenomenon, also known as "halo-eczema," has been widely described over melanocytic and non-melanocytic lesions. However, its appearance over vascular anomalies is rarely observed and could lead to diagnostic errors. A case study of five patients aged between four months and two years is reported. These patients developed unique erythematous and pruritic scaly patches, being diagnosed and treated as fungal infections. Due to the lack of response to the treatment, they were referred to the pediatric dermatology practice, where the diagnosis of Meyerson phenomenon over capillary malformations was made. Topical treatment with corticosteroids led to improvement in all cases. Although Meyerson phenomenon developing over vascular anomalies is a rare condition, it is important for pediatricians and dermatologists to assess it as a part of the differential diagnosis when treating a patient with skin lesions. Recognizing this phenomenon will prevent diagnostic and therapeutic errors.Ye
Skin Barrier Function in Psoriasis and Atopic Dermatitis: TransepidermalWater Loss and Temperature as Useful Tools to Assess Disease Severity
Multiple diagnostic tools are used to evaluate psoriasis and atopic dermatitis (AD) severity, but most of them are based on subjective components. Transepidermal water loss (TEWL) and temperature are skin barrier function parameters that can be objectively measured and could help clinicians to evaluate disease severity accurately. Thus, the aims of this study are: (1) to compare skin barrier function between healthy skin, psoriatic skin and AD skin; and (2) to assess if skin barrier function parameters could predict disease severity. A cross-sectional study was designed, and epidermal barrier function parameters were measured. The study included 314 participants: 157 healthy individuals, 92 psoriatic patients, and 65 atopic dermatitis patients. TEWL was significantly higher, while stratum corneum hydration (SCH) (8.71 vs. 38.43 vs. 44.39 Arbitrary Units (AU)) was lower at psoriatic plaques than at uninvolved psoriatic skin and healthy controls. Patients with both TEWL > 13.85 g m-2h-1 and temperature > 30.85 C presented a moderate/severe psoriasis (psoriasis area severity index (PASI) 7), with a specificity of 76.3%. TEWL (28.68 vs. 13.15 vs. 11.60 g m-2 h-1) and temperature were significantly higher, while SCH (25.20 vs. 40.95 vs. 50.73 AU) was lower at AD eczematous lesions than uninvolved AD skin and healthy controls. Patients with a temperature > 31.75 C presented a moderate/severe AD (SCORing Atopic Dermatitis (SCORAD) 37) with a sensitivity of 81.8%. In conclusion, temperature and TEWL values may help clinicians to determine disease severity and select patients who need intensive treatment